Research
Current Research
Acorn:
Acorn is a Canadian startup company specializing in regenerative medicine based on human stem cells. Currently there is a significant amount of research on the many treatment possibilities of stem cells and as person interested in the future of aesthetics we had to be a part of it! We are currently researching the effects of personalized secretosomes on facial skin rejuvenation and hair growth in the scalp.
Sofwave:
Dr. Jean Carruthers is leading a clinical research study on how to treat “Ozempic face” (the sagging and hollowing of the face after rapid weight loss) with Sofwave skin tightening.
The aim of the study is to demonstrate whether early treatment of Ozempic face is better for the self esteem and appearance of weight loss journey subjects than later treatment.
Past Research
Botox Cosmetic:
Dr. Jean Carruthers has played a pivotal role in the development of many aspects of today’s cosmetics industry. Most significantly, she pioneered the cosmetic use of botulinum A exotoxin (“Botox”) back in the 80s, along with her husband, Dr. Alastair Carruthers.
Dr. Jean first used Botox on patients with blepharospasm, a condition that causes facial muscle spasms that force eyelids shut. After one of her blepharospasm patients noticed how the treatment softened the lines on her face, Jean and Alastair started a clinical trial to research this fortuitous discovery. After many presentations and multi-author clinical trials, Botox’s popularity has grown to become the most commonly performed cosmetic procedure in the world.
Alastin Skincare:
Dr. Jean Carruthers has worked with Alastin Skincare on its revolutionary cream, TransFORM Body Treatment.
In her research, she found that trihex peptide creates new elastic tissue in skin, which is exactly what is needed when we see our skin begin to sag. Dr. Carruthers has developed a machine that measures the elasticity of human skin and is using it in clinical trials to evaluate the response to topical creams.
